Rankings
▼
Calendar
SMMT FY 2023 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$2M
Operating Income
-$90M
Net Income
-$615M
EPS (Diluted)
$-0.99
Cash Flow
Operating Cash Flow
-$77M
Free Cash Flow
-$77M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$203M
Total Liabilities
$125M
Stockholders' Equity
$78M
Cash & Equivalents
$71M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$704,295
-100.0%
Gross Profit
-$2M
-$2M
-13.3%
Operating Income
-$90M
-$60M
-50.5%
Net Income
-$615M
-$79M
-680.5%
← Q4 2022
All Quarters
Q1 2023 →